Hints and tips:
...Leerink, who will be chair and chief executive of the business....
...The lawsuit plaintiffs allege that the transaction process “violated several requirements of the LLC agreement” and that SVP “obscured the Company’s asset valuations and concealed critical information from...
...IVC’s owners brought in former WHSmith chief executive Kate Swann to chair the group in 2019, and added another former head of the stationery group, Clarke, as chief executive last year....
...Ms Swann declined to comment....
...Analysts with investment bank Leerink Partners said the deal could face an easier path to regulatory approval than a $17.2bn transaction proposed between Walgreens and Rite Aid in 2015....
...GW Pharmaceuticals rose 3.3 per cent to 296.5p, a record high, after Leerink Swann issued “buy” advice....
...A BMS bid for Shire “makes sense” though any anti-takeover measures were likely to be “purely precautionary”, Leerink Swann analysts said....
...“While Mr Soriot didn’t completely close the door on major M&A, management’s commitment to the current progressive dividend policy suggests megadeals are unlikely at least through 2016,” said Leerink Swann...
...Leerink Swann, the brokerage, said in a research note that given the company’s “shallow late-stage pipeline”, it expected “the new CEO to be particularly aggressive on M&A” with larger cash deals focused...
...“An Obama victory ratifies the status quo,” said John Sullivan, healthcare analyst at Leerink Swann....
...Analysts at Leerink Swann reckon he should buy Forest Laboratories (FRX), the New York City-based maker of treatments for anxiety and alcoholism....
...“We were expecting them to do something to offset the $10-11bn in lost revenues from Express Scripts,” said David Larsen, healthcare analyst at Leerink Swann....
...Swann on Monday....
...The SEC is also investigating whether Leerink Swann, a firm which runs a so-called “expert network”, leaked information to investors in its capacity as an advisor to Cougar....
...Swann....
...Analysts at Leerink Swann said last September that signs of success in Bristol’s drug pipeline would give it greater flexibility to look for acquisitions....
...Migratory Swann Would you like a large Dairy Milk with your City column? No? But you cannot blame us for copying Kate Swann, the tenacious boss of WH Smith....
...“This cut will wipe out a significant portion of their earnings, and will also likely cause debt covenants to be broken in certain cases,” said Jason Furda, analyst at Leerink Swann....
...“The last couple of years have been challenging for J&J,” said Rick Wise, an analyst at Leerink Swann, noting the company’s series of recalls and the impact of the tough economy....
...Adam Berger, head of M&A at Leerink Swann, said: “Before a few years ago, it was rare to see a CVR in public deals. “This is by far the biggest deal that it has been used in....
...Genzyme, the drugmaker, saw its shares rise 3.7 per cent to $53 after being raised to “outperform” by analysts at Leerink Swann, the healthcare specialist group....
...There will be pain ahead, with Leerink Swann, the healthcare specialist group, estimating rebates, discounts and taxes mean the long-term costs for the drug industry may exceed $100bn....
...Leerink Swann, the US healthcare-focused investment bank, estimated that, based on the different authorisations for the two vaccines, GSK could take 15-20 per cent of the US market for HPV vaccinations....
International Edition